Briery Christian M, Chauhan Suneet P, Magann Everett F, Cushman Julie L, Morrison John C
Willis Knighton Health System, 9111 Susan Drive, Shreveport, LA 71118, USA.
J Miss State Med Assoc. 2011 Mar;52(3):72-5.
Bacterial vaginosis (BV) is associated with preterm labor and may be positive in 15% of asymptomatic high-risk women. Fetal fibronectin (fFN) has been shown in symptomatic women to predict infection-related preterm birth. The purpose of this study was to quantitate the relationship between BV/fFN and preterm delivery in high-risk asymptomatic women.
Women at high-risk for spontaneous preterm delivery were tested for BV/fFN between 20-28 weeks gestation. Women positive for BV were treated with metronidazole, and fFN results were not used by physicians in treatment. After delivery, test results and pregnancy outcomes were entered in a deidentified database and analyzed.
Of 232 women tested for BV/fFN over a 24-month epoch, results divided participants into 4 groups: Group A (N = 12; +BV/+fFN); Group B (N = 22; -BV/+fFN); Group C (N = 68; +BV/-fFN); and Group D (N = 130; -BV/-fFN). Demographics were the same between the 4 groups (P = NS) as was the gestational age at delivery (36.41 +/- 3.96 to 37.18 +/- 3.03 weeks). The incidence ofpreterm labor (P = .075), spontaneous early delivery (P = .936) and infants < 2500 gm (P = .664) was also similar.
In asymptomatic high-risk women, testing for fFN/BV during mid-pregnancy does not appear warranted.
细菌性阴道病(BV)与早产相关,在15%无症状高危女性中可能呈阳性。胎儿纤连蛋白(fFN)已被证实在有症状的女性中可预测感染相关的早产。本研究的目的是量化高危无症状女性中BV/fFN与早产之间的关系。
对有自发早产风险的女性在妊娠20 - 28周时进行BV/fFN检测。BV检测呈阳性的女性用甲硝唑治疗,医生在治疗中不使用fFN检测结果。分娩后,将检测结果和妊娠结局录入一个去识别化的数据库并进行分析。
在24个月期间对232名女性进行了BV/fFN检测,结果将参与者分为4组:A组(N = 12;BV阳性/fFN阳性);B组(N = 2;BV阴性/fFN阳性);C组(N = 68;BV阳性/fFN阴性);D组(N = 130;BV阴性/fFN阴性)。4组之间的人口统计学特征相同(P =无显著性差异),分娩时的孕周也相同(36.41±3.96至37.18±3.03周)。早产(P = 0.075)、自发早产(P = 0.936)和出生体重<2500克的婴儿(P = 0.664)的发生率也相似。
在无症状高危女性中,妊娠中期检测fFN/BV似乎没有必要。